CTS effectively decreased the incidence of AAA, reduced the maximum diameter of the abdominal aorta, and increased the survival rate in Ang II-infused ApoE-/- mice, a well-established and clinically relevant model for studying AAA. The gene discussed is AGT; the disease is triple-A syndrome.